These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2006-000319-96 “Estudio de fase II/III, Multicéntrico, doble enmascarado, Aleatorizado, de Grupos paralelos, Con variacion de dósis, controlado para valorar la eficacia y seguridad de NOVA22007 (emulsión ocular cati... 2007-07-12 due-trials
Reported results 2007-000029-23 A Phase III, Multicenter, Randomized, Controlled, Double-Masked Trial of NOVA22007 (Ciclosporin 0.1%) Ophthalmic Cationic Emulsion versus Vehicle in Patients with Moderate to Severe Dry Eye Syndrome 2010-08-10 due-trials
Listed as ongoing, but also has a completion date and reported results 2011-000160-97 A MULTICENTER, RANDOMIZED, DOUBLE-MASKED, 2 PARALLEL ARM, VEHICLE CONTROLLED, 6-MONTH PHASE III TRIAL WITH A 6 MONTH OPEN LABEL TREATMENT SAFETY FOLLOW-UP PERIOD TO EVALUATE THE EFFICACY AND SAFETY... 2013-02-13 bad-data
Listed as ongoing, but also has a completion date 2012-002066-12 A Multicenter, Open Label, Interventional, Prospective, Non Randomized, One Cohort Extension Study To Assess the Sustainability of the Effect of NOVA22007 Following Treatment Discontinuation in Improv... 2014-10-13 bad-data
Reported results 2012-005060-10 A MULTICENTER, RANDOMIZED, DOUBLE-MASKED, 3 PARALLEL ARMS, PLACEBO CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF NOVA22007 1MG/ML (CICLOSPORIN/CYCLOSPORINE) EYE DROPS, EMULSION ADMINISTERED IN... 2016-02-01 due-trials

Related organisations

Over time organisations can merge, or split.

We think Novagali Pharma is now effectively part of Santen Pharmaceutical.